Patent classifications
C07D487/16
Fused tricyclic heterocycle compounds and therapeutic uses thereof
This application discloses a new class of fused tricyclic heterocycles of formula (I), preparation methods thereof, pharmaceutical compositions comprising these compounds, and pharmaceutically acceptable salts, solvates, or prodrugs thereof, and their uses for the treatment of diseases in which modulation of STING is beneficial, for example, cancers, pre-cancerous disorders, and viral infections. ##STR00001##
ORGANIC ELECTROLUMINESCENT DEVICE
The device provided herein is an organic electroluminescent device and includes a substrate; a first electrode on the substrate and with high reflectivity; a translucent or transparent second electrode over the first electrode; and a first, a second and a third organic layer included between the first and the second electrode; where the second organic layer has a thickness >80 nm and is made of a second organic material; the third organic layer is a light-emitting layer including at least one light-emitting material and at least one host material; the first organic layer has a conductivity >1×10.sup.−4 S/m and <1×10.sup.−2 S/m; an energy level difference between HOMO energy level of the second organic material and HOMO energy level of the at least one host material is <0.27 eV; and the first electrode and the second organic layer are in direct contact with the first organic layer.
ORGANIC ELECTROLUMINESCENT DEVICE
The device provided herein is an organic electroluminescent device and includes a substrate; a first electrode on the substrate and with high reflectivity; a translucent or transparent second electrode over the first electrode; and a first, a second and a third organic layer included between the first and the second electrode; where the second organic layer has a thickness >80 nm and is made of a second organic material; the third organic layer is a light-emitting layer including at least one light-emitting material and at least one host material; the first organic layer has a conductivity >1×10.sup.−4 S/m and <1×10.sup.−2 S/m; an energy level difference between HOMO energy level of the second organic material and HOMO energy level of the at least one host material is <0.27 eV; and the first electrode and the second organic layer are in direct contact with the first organic layer.
ELECTROLUMINESCENT DEVICE
Provided is an electroluminescent device. The organic electroluminescent device comprises an anode, a cathode and an organic layer disposed between the anode and the cathode, where the organic layer comprises a first compound having a structure of H-L-E and a second compound comprising a ligand L.sub.a having a structure of Formula C. Such a new material combination consisting of the first compound and the second compound can obtain higher efficiency in the device, significantly extend a lifetime, and provide better device performance. Further provided are a display assembly comprising the electroluminescent device and a compound combination.
ELECTROLUMINESCENT DEVICE
Provided is an electroluminescent device. The organic electroluminescent device comprises an anode, a cathode and an organic layer disposed between the anode and the cathode, where the organic layer comprises a first compound having a structure of H-L-E and a second compound comprising a ligand L.sub.a having a structure of Formula C. Such a new material combination consisting of the first compound and the second compound can obtain higher efficiency in the device, significantly extend a lifetime, and provide better device performance. Further provided are a display assembly comprising the electroluminescent device and a compound combination.
COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
Provided is a compound of Formula 1:
##STR00001## wherein: X and Y are independently O, S, or CZ1Z2; Ring A is a benzene or naphthalene ring; A1 to A4 are independently hydrogen, deuterium, a halogen group, a cyano group, a nitro group, a hydroxyl group, or a substituted or unsubstituted: alkyl, cycloalkyl, aryl, or heterocyclic group; R1 to R6, Z1, and Z2 are independently a substituted or unsubstituted: alkyl, aryl, or heterocyclic group; n1 to n3, m, and l are 0 or 1 and n1+n2+n3 is ≥2; a1 and a2 are 1 to 4; a3 is 1 to 3; a4 is 1 to 6; and when a1 to a4 are each 2 or higher, structures in the parenthesis are the same or different, provided that when Ring A is naphthalene, m is 0, and when l is 1, Ring A is a benzene ring,
and an organic light-emitting device comprising the compound.
COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
Provided is a compound of Formula 1:
##STR00001## wherein: X and Y are independently O, S, or CZ1Z2; Ring A is a benzene or naphthalene ring; A1 to A4 are independently hydrogen, deuterium, a halogen group, a cyano group, a nitro group, a hydroxyl group, or a substituted or unsubstituted: alkyl, cycloalkyl, aryl, or heterocyclic group; R1 to R6, Z1, and Z2 are independently a substituted or unsubstituted: alkyl, aryl, or heterocyclic group; n1 to n3, m, and l are 0 or 1 and n1+n2+n3 is ≥2; a1 and a2 are 1 to 4; a3 is 1 to 3; a4 is 1 to 6; and when a1 to a4 are each 2 or higher, structures in the parenthesis are the same or different, provided that when Ring A is naphthalene, m is 0, and when l is 1, Ring A is a benzene ring,
and an organic light-emitting device comprising the compound.
ORGANIC ELECTROLUMINESCENCE ELEMENT, COMPOSITION, POWDER, ELECTRONIC EQUIPMENT, AND NOVEL COMPOUND
An organic electroluminescence device including: a cathode; an anode; and at least one emitting layer disposed between the cathode and the anode, wherein the emitting layer contains a first host material, a second host material, and a dopant material, wherein the first host material is a compound represented by the following formula (1), the second host material is a compound represented by the following formula (2), and the first host material and the second host material are different compounds.
##STR00001##
MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
Compounds, methods of use, and processes for making inhibitors of complement factor D or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade. The inhibitors of factor D described herein reduce excessive activation of complement.
ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
An organic electroluminescence device includes an anode, a cathode, a first emitting layer, and a second emitting layer provided between the first emitting layer and the cathode, in which the first emitting layer includes, as a first host material, a first compound that includes at least one group represented by a formula (11) below, the first compound being represented by a formula (1) below, the second emitting layer includes a second compound represented by a formula (2) below as a second host material, and the first emitting layer is in direct contact with the second emitting layer. L.sub.101 is a single bond or a substituted or unsubstituted arylene group having 6 to 50 ring carbon atoms. Ar.sub.101 is a substituted or unsubstituted aryl group having 6 to 50 ring carbon atoms. mx is 0, 1, 2, 3, 4, or 5.
##STR00001##